| Developmental abnormalities |
phenotype |
2 |
1 |
|
| developmental changes |
phenotype |
2 |
1 |
|
| developmental delay |
phenotype |
16 |
6 |
DD, slowed developmental process |
| developmental disabilities |
phenotype |
4 |
1 |
developmental disability |
| developmental disorders |
phenotype |
7 |
5 |
DD |
| developmental outcomes |
phenotype |
2 |
1 |
|
| developmental psychopathology |
phenotype |
2 |
1 |
|
| developmental stage |
phenotype |
6 |
3 |
developmental stages |
| developmental stress |
phenotype |
2 |
2 |
developmental stress |
| developmental trajectory |
phenotype |
3 |
1 |
mixed model trajectory slopes, s(t), trajectory estimates |
| deviance |
phenotype |
2 |
1 |
blackmail, deviance, substantial damage to property, theft, violence |
| deviant behavior |
phenotype |
6 |
3 |
deviance proneness, deviant, deviant behavior |
| deviant peers |
phenotype |
15 |
15 |
affiliation with delinquent peers, affiliation with deviant peers, choice of delinquent peers, deviant peer affiliation, deviant peer groups, deviant peers, marginalized groups of peers engaging in deviant behavior, peer affiliation, peer deviance, substance-using peers |
| dexamethasone |
drug |
4 |
2 |
|
| dextrose |
drug |
5 |
2 |
|
| DFNB31 |
gene |
2 |
2 |
|
| Dgkh |
gene |
4 |
3 |
diacylglycerol kinase, eta |
| DHA |
drug |
2 |
— |
docosahexaenoic acid |
| DHFRL1 |
gene |
2 |
2 |
|
| DHS |
drug |
5 |
2 |
DNAse hypersensitivity sites |
